Lysosomal targeting of immunogens

Details Lysosomal targeting of immunogens Lysosomal targeting of immunogens

A - Human Necessities

61

K

A61K 39/00 (2006.01) C07K 14/705 (2006.01) C07K 14/74 (2006.01)

Patent

CA 2154445

The inventors have discovered a targeting signal that will direct proteins to the endosomal/lysosomal compartment, and they have demonstrated that chimeric proteins containing a luminal antigenic domain and a cytoplasmic endosomal/lysosomal targeting signal will effectively target antigens to that compartment, where the antigenic domain is processed and peptides from it are presented on the cell surface in association with major histocompatibility (MHC) class II molecules. Chimeric DNA encoding the antigen of interst, linked to an endosomal/lysosomal targeting sequence, inserted in an immunization vector, can introduce the chimeric genes into cells, where the recombinant antigens are expressed and targeted to the endosomal/lysosomal compartment. As a result, the antigens associate more efficiently with MHC class II molecules, providing enhanced in vivo stimulation of CD4+ T cells specific for the the recombinant antigen. Delivering antigens to an endosomal/lysosomal compartment by means of chimeric constructs containing such lysosomal targeting signals will be of value in any vaccination or immunization strategy that seeks to stimulate CD4+ MHC class II restricted immune responses.

Affiliated with

Also associated with

Rating

Lysosomal targeting of immunogens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lysosomal targeting of immunogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lysosomal targeting of immunogens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1632489